RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients

Corinna Keup, Bahriye Aktas, Mitra Tewes, +5

Clinical Chemistry

Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients

Corinna Keup, Karim Benyaa, Siegfried Hauch, +6

Cellular and Molecular Life Sciences

Application of dual reading domains as novel reagents in chromatin biology reveals a new H3K9me3 and H3K36me2/3 bivalent chromatin state

Rebekka Mauser, Goran Kungulovski, Corinna Keup, +2

Epigenetics & Chromatin

Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer

Corinna Keup, Vinay Suryaprakash, Siegfried Hauch, +8

Genome Medicine

Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients

Corinna Keup, Vinay Suryaprakash, Markus Storbeck, +3

Cells

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer

Corinna Keup, Markus Storbeck, Siegfried Hauch, +6

Cancers

Multimodal Targeted Deep Sequencing of Circulating Tumor Cells and Matched Cell-Free DNA Provides a More Comprehensive Tool to Identify Therapeutic Targets in Metastatic Breast Cancer Patients

Corinna Keup, Markus Storbeck, Siegfried Hauch, +5

Cancers

Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast Cancer

Sabine Kasimir‐Bauer, Corinna Keup, Oliver Hoffmann, +3

Frontiers in Oncology

Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple‐negative breast cancer patients

Ann‐Kathrin Bittner, Corinna Keup, Oliver Hoffmann, +3

Journal of Cellular and Molecular Medicine

Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancer

Stefanos Ioannis Moukas, Sabine Kasimir‐Bauer, Mitra Tewes, +4

Scientific Reports